What are the risks of famciclovir for pregnant women?

Why do doctors limit famciclovir use in pregnancy?

Famciclovir is not recommended during pregnancy because animal studies show fetal harm at doses equivalent to human exposure. No adequate human studies exist, and current guidelines classify it as Pregnancy Category B with a pregnancy registry that tracked only a small number of women.

What alternatives exist if a pregnant woman needs herpes treatment?

Acyclovir is the preferred antiviral for pregnant women with herpes infections. It has more safety data and enters clinical practice guidelines as the first-line option. Valacyclovir also appears in some protocols as a second choice when acyclovir cannot be used.

How does famciclovir affect a fetus?

Animal data show reduced fetal weight and skeletal variations at doses near human exposure levels. Human case reports remain rare and inconclusive. The pregnancy registry maintained by the manufacturer recorded outcomes for fewer than 50 women, yielding no clear signal of increased malformation rates.

When does the famciclovir patent expire?

The primary compound patent for famciclovir expired years ago, allowing generic versions to dominate the market. Generic manufacturers now dominate supply and pricing, but active ingredient protection has already run its course.

Why are companies challenging this patent?

No active compound challenges remain. Early disputes focused on formulation or method-of-use patents rather than the core molecule. Those secondary claims have largely expired or been invalidated.

What side effects are patients asking about?

Pregallant women report concerns about premature delivery, low birth weight, and malformation risk. Non-pregnant users commonly cite nausea, headache, and confusion. Registries and spontaneous reports highlight pregnancy-specific worries rather than daily-use issues.

Can biosimilars enter before patent expiry?

Famciclovir is a small-molecule drug rather than a biological. Biosimilars do not apply. Generic versions entered the market after compound patent expiry, allowing multiple manufacturers to compete on price.

DrugPatentWatch.com